Ferrari F, Giuliani D
Department of Biomedical Sciences, University of Modena, Italy.
Pharmacol Biochem Behav. 1996 Mar;53(3):525-30. doi: 10.1016/0091-3057(95)02045-4.
The influence of the DA D2 antagonist (-) eticlopride on cocaine- and DA D2 agonist-induced behavioral effects was investigated by means of two series of experiments, in rats. In the first 10-day series, coadministration of (-) eticlopride (10 and 50 micrograms/kg, SC) always potently inhibited cocaine (15 mg/kg, IP)-induced hypermotility but did not modify the penile erection (PE)-enhancement produced by the drug at the first injection; it actually counteracted the inhibitory effect of subchronic cocaine on PE. In the second series, (-) eticlopride, at the same doses, antagonized PE elicited by various DA D2 agonists at nonstereotyping doses; when, along with PE, stereotyped behavior was induced, only the latter was inhibited by (-) eticlopride, which even increased PE.
通过在大鼠身上进行的两个系列实验,研究了多巴胺D2拮抗剂(-)依托必利对可卡因和多巴胺D2激动剂诱导的行为效应的影响。在第一个为期10天的系列实验中,联合给予(-)依托必利(10和50微克/千克,皮下注射)总是能有效抑制可卡因(15毫克/千克,腹腔注射)诱导的运动亢进,但不会改变该药物首次注射时产生的阴茎勃起(PE)增强效应;实际上,它抵消了亚慢性可卡因对PE的抑制作用。在第二个系列实验中,相同剂量的(-)依托必利拮抗了各种非刻板剂量的多巴胺D2激动剂引发的PE;当与PE一起诱导出刻板行为时,只有后者被(-)依托必利抑制,而(-)依托必利甚至增强了PE。